Aurinia Pharmaceuticals (LTS:0UJF) 3-Year Book Growth Rate : -6.50% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aurinia Pharmaceuticals 3-Year Book Growth Rate?

Aurinia Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was C$3.39.

During the past 12 months, Aurinia Pharmaceuticals's average Book Value per Share Growth Rate was -8.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -6.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 11.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Aurinia Pharmaceuticals was 83.70% per year. The lowest was -47.30% per year. And the median was -9.05% per year.

Competitive Comparison of Aurinia Pharmaceuticals's 3-Year Book Growth Rate

For the Biotechnology subindustry, Aurinia Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurinia Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aurinia Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Aurinia Pharmaceuticals's 3-Year Book Growth Rate falls into.

Aurinia Pharmaceuticals 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Aurinia Pharmaceuticals (LTS:0UJF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Aurinia Pharmaceuticals 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Aurinia Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurinia Pharmaceuticals (LTS:0UJF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurinia Pharmaceuticals Inc (LTS:0UJF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

AUPH:USA IKAP:Germany

Address

4464 Markham Street, Suite 1203, Victoria, BC, CAN, V8Z 7X8

Website

https://www.auriniapharma.com

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Aurinia Pharmaceuticals (LTS:0UJF) Headlines

No Headlines